-
公开(公告)号:US07960544B2
公开(公告)日:2011-06-14
申请号:US12097616
申请日:2006-12-18
申请人: Wilmin Bartolini , Brian M. Cali , Barbara Chen , Yueh-Tyng Chien , Mark G. Currie , G. Todd Milne , James Philip Pearson , John Jeffrey Talley , Jane Yang , Craig Zimmerman , Charles Kim , Kevin Sprott , Timothy Barden , Regina Lundigran , Ara Mermerian
发明人: Wilmin Bartolini , Brian M. Cali , Barbara Chen , Yueh-Tyng Chien , Mark G. Currie , G. Todd Milne , James Philip Pearson , John Jeffrey Talley , Jane Yang , Craig Zimmerman , Charles Kim , Kevin Sprott , Timothy Barden , Regina Lundigran , Ara Mermerian
IPC分类号: C07D403/06 , C07D239/26 , C07D471/04 , C07D401/06 , C07D271/06 , C07D271/10 , C07D417/06 , C07D413/06 , C07D263/32 , C07D261/08
CPC分类号: C07D209/42 , C07D209/30 , C07D401/06 , C07D409/06 , C07D417/06
摘要: Indoles that have activity as inhibitors of FAAH are described as are indoles and indole derivatives that have activity as inhibitors of DAO.
摘要翻译: 具有作为FAAH抑制剂的活性的吲哚被描述为具有作为DAO抑制剂的活性的吲哚和吲哚衍生物。
-
公开(公告)号:US20090264653A1
公开(公告)日:2009-10-22
申请号:US12097616
申请日:2006-12-18
申请人: Wilmin Bartolini , Brian M Cali , Barbara Chen , Yueh-Tyng Chien , Mark G. Currie , G. Todd Milne , James Philip Pearson , John Jeffrey Talley , Jane Yang , Craig Zimmerman , Charles Kim , Kevin Sprott , Timothy Barden , Regina Lundigran , Ara Mermerian
发明人: Wilmin Bartolini , Brian M Cali , Barbara Chen , Yueh-Tyng Chien , Mark G. Currie , G. Todd Milne , James Philip Pearson , John Jeffrey Talley , Jane Yang , Craig Zimmerman , Charles Kim , Kevin Sprott , Timothy Barden , Regina Lundigran , Ara Mermerian
IPC分类号: C07D413/14 , C07D209/04 , C07D235/00 , C07D403/04 , C07D215/02 , C07D471/02
CPC分类号: C07D209/42 , C07D209/30 , C07D401/06 , C07D409/06 , C07D417/06
摘要: Indoles that have activity as inhibitors of FAAH are described as are indoles and indole derivatives that have activity as inhibitors of DAO.
摘要翻译: 具有作为FAAH抑制剂活性的吲哚被描述为具有作为DAO抑制剂的活性的吲哚和吲哚衍生物。
-
公开(公告)号:US08884020B2
公开(公告)日:2014-11-11
申请号:US12309993
申请日:2007-08-07
申请人: John Jeffrey Talley , Kevin Sprott , James Philip Pearson , G. Todd Milne , Wayne Schairer , Jane Yang , Charles Kim , Timothy Barden , Regina Lundrigan , Ara Mermerian , Mark G. Currie
发明人: John Jeffrey Talley , Kevin Sprott , James Philip Pearson , G. Todd Milne , Wayne Schairer , Jane Yang , Charles Kim , Timothy Barden , Regina Lundrigan , Ara Mermerian , Mark G. Currie
IPC分类号: C07D209/18 , C07D209/22 , C07D401/06
CPC分类号: C07D209/18 , C07D209/22 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/06 , C07D413/14 , C07D417/14 , C07D498/04
摘要: Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
摘要翻译: 描述了可用于治疗疼痛,炎症和其它病症的吲哚衍生物。 某些化合物是苄基衍生物,而其它化合物是苯甲酰基衍生物。 该化合物至少在吲哚的3位被取代。
-
公开(公告)号:US20100197708A1
公开(公告)日:2010-08-05
申请号:US12309993
申请日:2007-08-07
申请人: John Jeffrey Talley , Kevin Sprott , James Philip Pearson , G. Todd Milne , Wayne Schairer , Jane Yang , Charles Kim , Timothy Barden , Regina Lundrigan , Ara Mermerian , Mark G. Currie
发明人: John Jeffrey Talley , Kevin Sprott , James Philip Pearson , G. Todd Milne , Wayne Schairer , Jane Yang , Charles Kim , Timothy Barden , Regina Lundrigan , Ara Mermerian , Mark G. Currie
IPC分类号: A61K31/506 , C07D401/12 , A61K31/4439 , C07D209/22 , A61K31/4045 , C07D403/12 , A61P3/04 , A61P25/06 , A61P29/00 , A61P25/22 , A61P27/06 , A61P37/08 , A61P11/06
CPC分类号: C07D209/18 , C07D209/22 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/06 , C07D413/14 , C07D417/14 , C07D498/04
摘要: Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
摘要翻译: 描述了可用于治疗疼痛,炎症和其它病症的吲哚衍生物。 某些化合物是苄基衍生物,而其它化合物是苯甲酰基衍生物。 该化合物至少在吲哚的3位被取代。
-
公开(公告)号:US20090118503A1
公开(公告)日:2009-05-07
申请号:US12143078
申请日:2008-06-20
IPC分类号: C07D413/02 , C07D401/12 , C07D209/04
CPC分类号: C07D401/12 , C07D209/18 , C07D209/32 , C07D401/14 , C07D403/06 , C07D409/06 , C07D413/06 , C07D413/14 , C07D417/14 , C07D498/04
摘要: Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
摘要翻译: 描述了可用于治疗疼痛,炎症和其它病症的吲哚衍生物。 某些化合物是苄基衍生物,而其它化合物是苯甲酰基衍生物。 该化合物至少在吲哚的3位被取代。
-
6.Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain 审中-公开
标题翻译: 使用FAAH抑制剂治疗腹部,内脏和骨盆疼痛公开(公告)号:US20130224151A1
公开(公告)日:2013-08-29
申请号:US13637761
申请日:2011-03-31
IPC分类号: A61K31/404 , A61K45/06 , A61K31/4439 , A61K31/325 , C07D209/22 , C07D401/12
CPC分类号: A61K31/404 , A61K31/00 , A61K31/325 , A61K31/40 , A61K31/4439 , A61K45/06 , C07D209/22 , C07D401/12
摘要: The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors alone or in combination for the treatment or prevention of abdominal, visceral or pelvic pain. Also described herein are pharmaceutical compositions comprising a FAAH inhibitor, alone or in combination with an additional therapeutic agent for the treatment of abdominal, visceral or pelvic pain.
摘要翻译: 本公开涉及单独或组合使用脂肪酸酰胺水解酶(FAAH)抑制剂来治疗或预防腹部,内脏或骨盆疼痛的方法。 本文还描述了包含FAAH抑制剂的药物组合物,其单独或与用于治疗腹部,内脏或骨盆疼痛的另外的治疗剂组合。
-
7.Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome 审中-公开
标题翻译: 使用FAAH抑制剂治疗帕金森病和不宁腿综合征公开(公告)号:US20130150346A1
公开(公告)日:2013-06-13
申请号:US13520644
申请日:2011-01-07
IPC分类号: A61K31/4439 , C07D209/22 , A61K31/404 , C07D403/14 , A61K31/506 , A61K31/223 , A61K31/195 , A61K31/165 , A61K31/26 , A61K31/12 , A61K31/4985 , A61K31/48 , A61K31/428 , A61K31/381 , A61K31/437 , A61K31/473 , A61K31/55 , A61K31/137 , A61K31/4458 , A61K31/136 , A61K31/16 , C07D401/12
CPC分类号: A61K31/4439 , A61K31/00 , A61K31/12 , A61K31/136 , A61K31/137 , A61K31/16 , A61K31/165 , A61K31/195 , A61K31/223 , A61K31/26 , A61K31/381 , A61K31/404 , A61K31/405 , A61K31/428 , A61K31/437 , A61K31/4458 , A61K31/473 , A61K31/48 , A61K31/4985 , A61K31/506 , A61K31/55 , A61K45/06 , C07D209/22 , C07D401/12 , C07D403/14 , A61K2300/00
摘要: The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.
摘要翻译: 本公开涉及使用脂肪酰胺水解酶(FAAH)抑制剂治疗帕金森病(PD),不宁腿综合征(RLS)和周期性肢体运动障碍(PLMD)的方面的方法,使用FAAH抑制剂来制造 用于治疗PD,RLS和PLMD的药物,以及包含用于治疗PD,RLS和PLMD的FAAH抑制剂的药学上可接受的组合物。
-
-
-
-
-
-